Temozolomide-Based Dry Powder Formulations for Lung Tumor-Related Inhalation Treatment

Author： Wauthoz Nathalie   Deleuze Philippe   Saumet Amandine   Duret Christophe   Kiss Robert   Amighi Karim  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.28, Iss.4, 2011-04, pp. : 762-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low powder mass filling of dry powder inhalation formulations

By Eskandar Fadi   Lejeune Morgane   Edge Stephen  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 1, 2011-01 ,pp. : 24-32

Informa Healthcare

Access to resources Recommend Favorite

Influence of carrier surface fines on dry powder inhalation formulations

By Boshhiha Antesar   Urbanetz Nora  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 8, 2009-08 ,pp. : 904-916

Informa Healthcare

Access to resources Recommend Favorite

Brain Tumor-Related Epilepsy

By  

Current Neuropharmacology, Vol. 10, Iss. 2, 2012-06 ,pp. : 124-133

Bentham Science Publishers

Access to resources Recommend Favorite

Mannitol Dry Powder for Inhalation: In Patients with Cystic Fibrosis

By Burness Celeste B.   Keating Gillian M.  

Drugs, Vol. 72, Iss. 10, 2012-07 ,pp. : 1411-1421

Adis International

Access to resources Recommend Favorite

Formulation and Evaluation of Insulin Dry Powder for Inhalation

By Mahesh Kumar T.   Misra Ambikanandan  

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 6, 2006-06 ,pp. : 677-686

Informa Healthcare

Access to resources Recommend Favorite